USPTO serial 79367129
SPARTHA MEDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 26, 2024
- Examiner
- GANESH, HARINI
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SPARTHA MEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, DeLuca, and Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Sanitary products for medicine, namely, sanitary preparations for medical use; ] antibacterial, biocidal, virucidal and antimicrobial sprays; anti-inflammatory sprays; [ medicinal preparations for the mouth, nose and ears as sprays; antiseptic sprays in the form of aerosols for the skin; antiseptic sprays in aerosol form for hard surfaces; sterilizing solutions, namely, sterilizing preparations; sanitary products for sterilization; ] biocidal, bactericidal, virucidal, microbicidal, germicidal solutions; anti-inflammatory solutions; [ antibacterial preparations in the nature of antibacterial soap, antimicrobial preparations for inhibiting and killing bacteria, and antiviral preparations; ] anti-inflammatory preparations; [ disinfectants; antiseptics; biocides; germicides; antiviral agents, namely, antiviral disinfectants and antiviral coatings to treat the growth of viruses on various surfaces; antibacterial products for washing hands, namely, antibacterial hand soaps; antiseptic preparations for the treatment of wounds; articles for dressings, materials for dressing wounds, liquid dressings for skin wounds, namely, medical and surgical dressings, sterilized dressings, self-adhesive dressings, and wound dressings; disinfectants for hygienic use; disinfectant impregnated wipes for sanitary use; bath preparations for medical use; ] chemical preparations for medical or veterinary use, namely, for treating viral, bacteriological and fungal infections; biological preparations for the treatment of viral, bacteriological and fungal infections; [ amino acids for medical or veterinary use; biological tissue cultures for medical use; cultures of microorganisms for medical or veterinary use; lining materials for dental use; ] biocides in the nature of antibacterial, antimicrobial and antiviral coatings for preventing and treating the development of viruses, microbes and bacteria on various surfaces; all the aforesaid goods being for medical, surgical, dental or veterinary use | ACTIVE | — |
| 010 | [ Surgical apparatus and instruments for medical, dental and veterinary use; ] applicators for antibacterial, antimicrobial and antiviral preparations in the nature of vaporizers for medical use; applicators for antiseptic preparations in the nature of vaporizers for medical use; applicators for anti-inflammatory preparations in the nature of vaporizers for medical use; [ nebulizers for medical use; ] vaporizers for medical use; [ suture materials; prostheses, namely, hip prostheses, shoulder prostheses, breast prostheses, dental prostheses, bone prostheses, facial prostheses, mandibular prostheses, and joint prostheses; artificial implants, namely, implants consisting of artificial materials; medical, surgical and orthopaedic implants consisting of artificial materials; fixation implants consisting of artificial material; orthopedic joint implants consisting of artificial materials; bone implants consisting of artificial materials; facial implants consisting of artificial materials; mandibular implants consisting of artificial materials; ocular implants consisting of artificial materials; dental implants consisting of artificial materials, and implants consisting primarily of artificial materials; special furniture for medical use; sterile surgical sheets; clothing especially for operating rooms; surgical masks and sanitary masks ] | ACTIVE | — |
| 040 | Made-to-order manufacturing and custom manufacturing of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings and solutions for the benefit of third parties; made-to-order manufacturing and custom manufacturing of anti-inflammatory coatings and solutions for the benefit of third parties; made-to-order manufacturing and custom manufacturing of antibacterial, antimicrobial and antiviral preparations * in the nature of coatings and solutions * for the benefit of third parties; [ made-to-order manufacturing and custom manufacturing of medical devices for the benefit of third parties; ] treatment of materials, namely, the addition of biosynthetic polymers to materials to make them bacteriostatic and bactericidal against bacteriological infections; treatment of materials, namely, metallic, polymer, electronic, plastic, silicone, ceramic or glass, paper, cardboard, rubber or textile materials, components and packaging by adding antimicrobial agents to protect against microbes, germs, viruses and bacteria; antimicrobial treatment of medical, surgical, dental and veterinary instruments and equipment against microbes, germs, viruses and bacteria; [ treatment of materials, namely, the addition of polymer additives and antimicrobial agents to materials used to manufacture medical devices, prostheses and artificial implants against microbes, germs, viruses and bacteria; antimicrobial treatment of medical devices, prostheses and artificial implants against microbes, germs, viruses and bacteria; anti-microbial treatment of electronic, optical, audiovisual, photographic equipment, computer hardware, data processing hardware, virtual or augmented reality hardware, helmets, head-mounted displays, gloves and 3D glasses, telecommunications apparatus, control devices, control apparatus for games and toys to protect against microbes, germs, viruses and bacteria; treatment and coating of metal surfaces; application of surface coatings to machines and tools for protective purposes by means of chemical, mechanical, thermal, thermo-mechanical, chemical vapor deposition, physical vapor deposition and vacuum deposition or by dipping processes in a solution; coating of eyeglasses and optical lenses for protective purposes by means of chemical, mechanical, thermal, thermo-mechanical, chemical vapor deposition, physical vapor deposition and vacuum deposition or by dipping processes in a solution; application of thin film coating for optical components; treatment of materials using chemicals; ] application of thin films to the surfaces of objects via chemical, mechanical, thermal, thermo-mechanical, chemical vapor deposition, physical vapor deposition and vacuum deposition or by dipping processes in a solution | ACTIVE | — |
| 042 | Designing and developing biocidal, microbicidal, virucidal, bactericidal and germicidal solutions and coatings customized for the benefit of third parties; designing and developing anti-inflammatory coatings and solutions for the benefit of third parties; designing and developing antibacterial, antimicrobial and antiviral preparations for the benefit of third parties; designing and developing medical devices for the benefit of third parties; scientific, biological and laboratory analysis services in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; laboratory services for medical research; scientific and technological services, namely, research and design services relating to biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; scientific and technological research in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; biological research; research in the field of physics; bacteriological research; chemical research; medical research; design, research and development of new products for others; engineering services in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; engineering services in the field of polymeric compounds, polymer synthesis, and materials customization for medical, hygienical, scientific, and technological applications; technical project studies, namely, conducting of feasibility studies in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical design, research, studies, analyses and surveys, in particular in the fields of health, treatments against microbes, germs, viruses and bacteria and artificial intelligence technologies; technological consultancy services in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; industrial analysis and research services, in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; industrial testing services in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; testing of materials; laboratory testing services in the nature of medical laboratory services and scientific laboratory services; medical and scientific research, namely, conducting clinical trials for others; cell culture services for scientific research purposes, for others; design, development, installation, updating, maintenance, rental and temporary provision of online artificial intelligence computer software for the development of customized medical devices and biocidal, microbicidal, virucidal, bactericidal, germicidal, anti-inflammatory solutions and coatings; software as a service (SaaS) and platform as a service (PaaS) featuring software and computer software platforms for processing and analyzing data and images and developing customized medical devices and biocidal, microbicidal, virucidal, bactericidal, germicidal, anti-inflammatory solutions and coatings | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SPARTHA MEDICAL
- Other trademarks owned by SPARTHA MEDICAL
- Other trademarks owned by SPARTHA MEDICAL
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named SPARTHA MEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2026 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Oct 5, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 9, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 22, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 22, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 26, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 25, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Feb 5, 2025 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Feb 5, 2025 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Feb 5, 2025 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 5, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 4, 2025 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 4, 2025 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Nov 29, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Nov 26, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 26, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 15, 2024 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 15, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Nov 3, 2024 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Sep 20, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 4, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 4, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 17, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jul 24, 2024 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jul 1, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 25, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 25, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 11, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 11, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 5, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 15, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 15, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 15, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 15, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 5, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 2, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 2, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 2, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 1, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 17, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 7, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |